Cisen Overview
- Year Founded
-
1970
- Status
-
Public
- Employees
-
3,000
- Stock Symbol
-
603367
- Investments
-
2
- Share Price
-
$1.90
- (As of Wednesday Closing)
Cisen General Information
Description
Cisen Pharmaceutical Co Ltd is engaged in Research, development, production and sales of pharmaceutical products.
Contact Information
Website
www.cisen-pharma.comCorporate Office
- Number 16 Tongji Road, High-tech Zone
- Jining, Shandong 272073
- China
Corporate Office
- Number 16 Tongji Road, High-tech Zone
- Jining, Shandong 272073
- China
Cisen Stock Performance
As of 18-Nov-2026, Cisen’s stock price is $1.90. Its current market cap is $859M with 453M shares.
(As of Wednesday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $1.90 | $1.90 | $1.78 - $2.89 | $859M | 453M | 6.32M | $0.12 |
Cisen Financials Summary
As of 30-Sep-2026, Cisen has a trailing 12-month revenue of $484M.
|
In Thousands, USD |
TTM 30-Sep-2026 | FY 2025 31-Dec-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 |
|---|---|---|---|---|
| EV | 447,858 | 724,833 | 536,283 | 602,641 |
| Revenue | 484,029 | 479,010 | 554,887 | 630,731 |
| EBITDA | 61,352 | 92,622 | 106,734 | 112,333 |
| Net Income | 56,158 | 58,577 | 70,923 | 73,689 |
| Total Assets | 1,154,530 | 1,085,864 | 1,034,755 | 1,035,160 |
| Total Debt | 3,984 | 6,221 | 15,868 | 24,077 |
Cisen Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Cisen Patents
Cisen Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2023241507-A1 | Crystal form of alkynylpyridine compound and preparation method therefor | Inactive | 13-Jun-2022 | ||
| WO-2023088370-A1 | Crystal form of fused-ring derivative and preparation method therefor | Inactive | 17-Nov-2021 | ||
| EP-4265607-A1 | Aminopyridine compound and application thereof | Pending | 15-Dec-2020 | ||
| EP-4265607-A4 | Aminopyridine compound and application thereof | Pending | 15-Dec-2020 | ||
| US-12492169-B2 | Aminopyridine compound and application thereof | Active | 15-Dec-2020 | C07D213/73 |
Cisen Signals
Cisen Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Cisen Investments (2)
Cisen’s most recent deal was a Secondary Transaction - Private with Guangzhou JOYO Pharma Company. The deal was made on 25-Apr-2018.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Guangzhou JOYO Pharma Company | 25-Apr-2018 | Secondary Transaction - Private | Pharmaceuticals | ||
| Joyo Pharma | 27-Mar-2018 | Secondary Transaction - Private | Drug Discovery |
Cisen ESG
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile
Pharmaceuticals
Industry
Rank
Percentile
Pharmaceuticals
Subindustry
Rank
Percentile
Cisen FAQs
-
When was Cisen founded?
Cisen was founded in 1970.
-
Where is Cisen headquartered?
Cisen is headquartered in Jining, China.
-
What is the size of Cisen?
Cisen has 3,000 total employees.
-
What industry is Cisen in?
Cisen’s primary industry is Pharmaceuticals.
-
Is Cisen a private or public company?
Cisen is a Public company.
-
What is Cisen’s stock symbol?
The ticker symbol for Cisen is 603367.
-
What is the current stock price of Cisen?
As of 18-Nov-2026 the stock price of Cisen is $1.90.
-
What is the current market cap of Cisen?
The current market capitalization of Cisen is $859M.
-
What is Cisen’s current revenue?
The trailing twelve month revenue for Cisen is $484M.
-
What is Cisen’s annual earnings per share (EPS)?
Cisen’s EPS for 12 months was $0.12.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process